This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

HMS Holdings Corp. Names Daniel Mendelson To Board Of Directors

Stocks in this article: HMSY

HMS Holdings Corp. (NASDAQ: HMSY) today announced that on February 20, 2013, Daniel N. Mendelson joined the company’s Board of Directors. Mr. Mendelson is the Chief Executive Officer of Avalere Health, a strategic advisory firm he founded in 2000. He is also presently Adjunct Professor at the Duke University Fuqua School of Business, and serves on the Board of Directors of Coventry Healthcare.

“Dan’s work has put him on the frontline of healthcare policy and business,” commented Bill Lucia, President and CEO of HMS. “We’re excited to welcome Dan to the Board and look forward to accessing his experience and knowledge as we continue to adapt our company to the changing healthcare environment.”

Mr. Mendelson’s areas of expertise include the Affordable Care Act, Medicare and Medicaid reform, and health system integration. Prior to founding Avalere, Mendelson served as Associate Director for Health at the White House Office of Management and Budget (OMB) where he was responsible for the full healthcare portfolio including Medicare and Medicaid. His work included implementation of the Children’s Health Insurance Program, development of the Medicare pharmaceutical benefit, Presidential initiatives in health information technology and medical error prevention and the electronic disease surveillance system.

Mr. Mendelson holds an undergraduate degree from Oberlin College, and a Masters in Public Policy from the Kennedy School of Government at Harvard University.

About HMS Holdings Corp.

HMS Holdings Corp., through its subsidiaries, is the nation's leader in coordination of benefits and program integrity services for healthcare payers. HMS's clients include health and human services programs in more than 40 states; commercial programs, including commercial plans, employers, and more than 148 Medicaid managed care plans; the Centers for Medicare and Medicaid Services (CMS); and Veterans Administration facilities. As a result of the company's services, clients recovered $3.2 billion in 2012, and saved billions more through the prevention of erroneous payments.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs